Skip to content

Author

A. Morishita

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Current Trends in the Novel Serological Protein and Blood-Based Biomarkers for Early Detection and Prognostic Prediction of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. HCC largely develops in patients with chronic liver diseases, including chronic hepatitis and liver cirrhosis. The surveillance in such patients is extremely important for the detection of HCC as soon as possible. The comprehensive mana...

Takashi Himoto, Koji Fujita, A. Morishita · 0 citations
Review Open access Sep 2026

Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence

Simple Summary Intrahepatic cholangiocarcinoma is an aggressive bile duct cancer that arises within the liver and frequently recurs after surgery. Administering anticancer treatment before surgery may treat occult disease earlier and help identify patients most likely to benefit from major liver surgery; however, this...

H. Suto, A. Morishita, H. Matsukawa et al. · 0 citations
Aug 2026

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.

CKD-related outcomes were more strongly associated with the burden of cardiometabolic abnormalities than with hepatic steatosis itself, and these associations were consistent in individuals with and without SLD.

Michihiro Iwaki, Hideki Fujii, Yoshihiro Kamada et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.